Differences in phenotype and gene expression of prostate stromal cells from patients of varying ages and their influence on tumour formation by prostate epithelial cells

Asian Journal of Andrology

Volumn 13, Issue 5, 2011, Pages 732-741

  Wang, Yong Chuan ^a   Yu, Sheng Qiang ^b   Wang, Xiao Hai ^a   Han, Bang Min ^a   Zhao, Fu Jun ^a   Zhu, Guang Hui ^a   Hong, Yan ^a   Xia, Shu Jie ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

coculture; gene expression; peripheral zone; phenotype; prostate cancer; stromal cells

Indexed keywords

COMPLEMENTARY DNA; RNA;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; NUDE MOUSE; PHENOTYPE; PROSTATE; PROSTATE CANCER; PROSTATE TUMOR; REAL TIME POLYMERASE CHAIN REACTION; STROMA CELL; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

AGE FACTORS; ANIMALS; BASE SEQUENCE; COCULTURE TECHNIQUES; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, NUDE; MICROSCOPY, ELECTRON, TRANSMISSION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATIC NEOPLASMS;

EID: 80052441279     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2011.11     Document Type: Article

References (46)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer Statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
2. Ross RK, Pike MC, Coetzee GA, Reichardt JK, Yu MC et al. Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Res 1998; 58: 4497-504.
3. Xia SJ, Hao GY, Tang XD. Androgen receptor isoforms in human and rat prostate. Asian J Androl 2000; 2: 307-10.
4. Xia SJ, Tang XD, Ma QZ. Androgen receptor isoforms in human prostatic cancer tissue and LNCaP cell line. Asian J Androl 2001; 3: 223-5.
5. Xia SJ, Xu CX, Tang XD, Wang WZ, Du DL. Apoptosis and hormonal milieu in ductal system of normal prostate and benign prostatic hyperplasia. Asian J Androl 2001; 3: 131-4.
6. Sampson N, Untergasser G, Plas E, Berger P. The ageing male reproductive tract. J Pathol 2007; 211: 206-18.
7. Bosland MC. The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monogr 2000; (27): 39-66.
8. Barclay WW, Woodruff RD, Hall MC, Cramer SD. A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer. Endocrinology 2005; 146: 13-8.
9. Cunha GR, Hayward SW, Wang YZ, Ricke WA. Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 2003; 107: 1-10.
10. Zhao FJ, Han BM, Yu SQ, Xia SJ. Tumor formation of prostate cancer cells influenced by stromal cells from the transitional or peripheral zones of the normal prostate. Asian J Androl 2009; 11: 176-82.
11. Verona EV, Elkahloun AG, Yang J, Bandyopadhyay A, Yeh IT et al. Transforming growth factor-beta signaling in prostate stromal cells supports prostate carcinoma growth by up-regulating stromal genes related to tissue remodeling. Cancer Res 2007; 67: 5737-46.
12. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the method. Methods 2001; 25: 402-8.
13. Zhang J, Hess MW, Thurnher M, Hobisch A, Radmayr C et al. Human prostatic smooth muscle cells in culture: estradiol enhances expression of smooth muscle cell-specific markers. Prostate 1997; 30: 117-29.
14. Sensibar JA, Pruden SJ, Kasjanski RZ, Rademaker A, Lee C et al. Differential growth rates in stromal cultures of human prostate derived from patients of varying ages. Prostate 1999; 38: 110-7.
15. Gmyrek GA, Walburg M, Webb CP, Yu HM, You X et al. Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor. Am J Pathol 2001; 159: 579-90.
16. Guo N, Ye JJ, Liang SJ, Mineo R, Li SL et al. The role of insulin-like growth factor-II in cancer growth and progression evidenced by the use of ribozymes and prostate cancer progression models. Growth Horm IGF Res 2003; 13: 44-53.
17. Kaminski A, Hahne JC, Haddouti el-M, Florin A, Wellmann A et al. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts. Int J Mol Med 2006; 18: 941-50.
18. Bavik C, Coleman I, Dean JP, Knudsen B, Plymate S et al. The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res 2006; 66: 794-802.
19. Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 2010; 5: 99-118.
20. Kuilman T, Peeper DS. Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer 2009; 9: 81-94.
21. DePinho RA. The age of cancer. Nature 2000; 408: 248-54.
22. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001; 411: 375-9.
23. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-7.
24. Krtolica A, Campisi J. Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int J Biochem Cell Biol 2002; 34: 1401-14.
25. Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA 2001; 98: 12072-7.
26. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004; 432: 332-7.
27. Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 2000; 89: 1800-9.
28. Pavelic J, Zeljko Z, Bosnar MH. Molecular genetic aspects of prostate transition zone lesions. Urology 2003; 62: 607-13.
29. Xia SJ, Xu XX, Teng JB, Xu CX, Tang XD. Characteristic pattern of human prostatic growth with age. Asian J Androl 2002; 4: 269-71.
30. Ben-Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 2005; 37: 961-76.
31. Itahana K, Campisi J, Dimri GP. Mechanisms of cellular senescence in human and mouse cells. Biogerontology 2004; 5: 1-10.
32. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999; 59: 5002-11.
33. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD et al. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 2002; 8: 2912-23.
34. Gerdes MJ, Larsen M, Dang TD, Ressler SJ, Tuxhorn JA et al. Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF-beta1. Prostate 2004; 58: 299-307.
35. Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP et al. Senescence- associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008; 6: 2853-68.
36. Coppe JP, Patil CK, Rodier F, Krtolica A, Beausejour CM et al. A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. PLoS One 2010; 5: e9188.
37. Nakashiro K, Okamoto M, Hayashi Y, Oyasu R. Hepatocyte growth factor secreted by prostate-derived stromal cells stimulates growth of androgen-independent human prostatic carcinoma cells. Am J Pathol 2000; 157: 795-803.
38. Naughton M, Picus J, Zhu X, Catalona WJ, Vollmer RT et al. Scatter factor-hepatocyte growth factor elevation in the serum of patients with prostate cancer. J Urol 2001; 165: 1325-8.
39. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003; 83: 835-70.
40. Xu ZD, Oey L, Mohan S, Kawachi MH, Lee NS et al. Hammerhead ribozyme-mediated cleavage of the human insulin-like growth factor-II ribonucleic acid in vitro and in prostate cancer cells. Endocrinology 1999; 140: 2134-44.
41. Miyake H, Pollak M, Gleave ME. Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models. Cancer Res 2000; 60: 3058-64.
42. Mohan S, Baylink DJ. IGF-binding proteins are multifunctional and act via GF-dependent and-independent mechanisms. J Endocrinol 2002; 175: 19-31.
43. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-74.
44. Dimri GP, Lee X, Basile G, Acosta M, Scott G et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92: 9363-7.
45. Pendergrass WR, Lane MA, Bodkin NL, Hansen BC, Ingram DK et al. Cellular proliferation potential during aging and caloric restriction in rhesus monkeys (Macaca mulatta). J Cell Physiol 1999; 180: 123-30.
46. Campisi J. Aging, tumor suppression and cancer: high wire-act! Mech Ageing Dev 2005; 126: 51-8.